Interestingly, ICC patients with high expression of both CD68 and PD1 showed a poorer prognosis compared to patients with high expression of only CD68 or PD1 and patients with low expression of both CD68 and PD1 (Fig. 5G,  P < 0.05). This evidence concerns the gene CD68 and intrahepatic cholangiocarcinoma.